about
How Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future DirectionsHuman monoclonal antibody-based therapy in the treatment of invasive candidiasisSerologic response to cell wall mannoproteins and proteins of Candida albicansBiochemical and immunological characterization of MP65, a major mannoprotein antigen of the opportunistic human pathogen Candida albicans.Cell wall and secreted proteins of Candida albicans: identification, function, and expressionPrediction of the clinical outcome in invasive candidiasis patients based on molecular fingerprints of five anti-Candida antibodies in serumPreclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90Antibody immunity and invasive fungal infectionsEvidence for presence in the cell wall of Candida albicans of a protein related to the hsp70 family.Importance of beta2-microglobulin in murine resistance to mucosal and systemic candidiasis.Genetically recombinant antibodies: new therapeutics against candidiasis.Production of antibodies to antigens of Candida albicans in CBA/H mice.Fungal heat-shock proteins in human disease.A critical review of typing methods for Candida albicans and their applications.HSP 90, yeasts and Corynebacterium jeikeiumProduction and function of cytokines in natural and acquired immunity to Candida albicans infection.Structure and regulation of the HSP90 gene from the pathogenic fungus Candida albicans.Glycolytic enzymes of Candida albicans are nonubiquitous immunogens during candidiasis.Detection of candidal antigens in autoimmune polyglandular syndrome type IGastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome.Anticandidal activity and interleukin-1 beta and interleukin-6 production by polymorphonuclear leukocytes are preserved in subjects with AIDS.Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome.Antigens and immune responses in Candida albicans infection.Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance.Serotype prevalence of Candida albicans from blood culture isolates.Guillain-Barré syndrome in immunocompromised patients: a report of three patients and review of the literature.Active and passive immunization against oral Candida albicans infection in a murine model.An immunodominant antigen of Candida albicans shows homology to the enzyme enolase.
P2860
Q26771113-E8B257DF-5938-41E4-886A-1CA23D08250BQ26864291-60CE66E1-D424-4208-883A-D19D930983D6Q33992594-9D0DA9A1-8649-4C13-8315-62E1A07BA191Q34003262-C2B4E580-C46C-4CC1-AACB-5C3FF626BB30Q34009982-C2281F46-3665-425B-A814-BCA79A48CCADQ34454950-8C9F49B8-2AC5-4580-81F9-3B41B2EE313FQ35102525-BB8BB4EF-19EE-4C1A-A3AC-9E8953D040BDQ35447692-30D56ECD-5B2C-4D0D-A7B8-E8CEC1E0AF70Q35513309-A51E1759-EC3A-45C0-AEF6-17AD4BD346C1Q35531651-89BFB1E1-B77B-440A-B752-3E7FDBAE58AFQ35681522-3AC1EEF1-9367-4B70-AC8E-D587FC6BAB8AQ35776977-5C3BBA8B-D1D3-4FAA-AA50-781D05379D6DQ36378357-98D59D46-483C-4692-AA7B-E4EAE41FD89EQ36495574-B949443B-8FBD-4896-9010-4E573A59C471Q36505768-1B00CD10-FA0A-4E3B-B78B-DB89448013AEQ36670422-865B0F4D-BB6F-46D2-B5CD-16C22E4859F4Q36685192-D6B85C2C-256E-4269-9491-97A15D3FE1E5Q36773592-456BE518-89C5-4227-8EFB-3EF5D3F1476CQ36807627-D385588C-C9AA-4433-9F9C-4E7B74061B76Q36965230-BD9B641C-5458-4FD5-A415-D682410CA8D4Q37068747-296977EC-5D9F-4F68-B565-81B460A110A8Q37175100-B775D723-692B-44C5-AD23-4A0444C0E79FQ37909862-23674C79-3EB7-451D-A752-367C59C9ABEEQ40156361-77D8E821-AC4F-4BB2-A930-373D4E7F5F7FQ40185025-B2584DCF-5467-4CA3-B763-299B3457DD68Q41543833-41597791-0B50-427B-B0E3-4DD7B5E8C03FQ43638634-5EB9D400-598B-40A0-952A-48551DC7D79EQ44343019-3CA930EE-2A70-46AC-B63F-3F05C138EF7F
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Candida and AIDS: evidence for protective antibody.
@en
Candida and AIDS: evidence for protective antibody.
@nl
type
label
Candida and AIDS: evidence for protective antibody.
@en
Candida and AIDS: evidence for protective antibody.
@nl
prefLabel
Candida and AIDS: evidence for protective antibody.
@en
Candida and AIDS: evidence for protective antibody.
@nl
P2093
P1433
P1476
Candida and AIDS: evidence for protective antibody.
@en
P2093
R Matthews
P304
P356
10.1016/S0140-6736(88)92547-0
P407
P577
1988-07-01T00:00:00Z